Henry Hagopian III - Chief Financial Officer at Annovis Bio, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
ANVS on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Henry Hagopian III since 21 Oct 2025

Reported holdings for Henry Hagopian III in Annovis Bio, Inc.

Form 4 holding Chief Financial Officer

Annovis Bio, Inc.

Security class
Common Stock
Shares / value
1,820
Estimated value
$11,102
Report date
20 Nov 2023
Price
$6.10
Ownership
Direct

Transaction history for Henry Hagopian III in Annovis Bio, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .